Security
Cytomx Therapeutics Inc. · COM
7 owners max 0.1% (Steve Cohen - Point72 Ass...)
owners
7
max %
0.1%
tracked value
$145M
qoq
A 4
R 2
holders
sorted by % of portfolio · long equity only
| manager | % port | activity | shares | value | history |
|---|---|---|---|---|---|
| Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 | 0.1% | Add +0.02 pp | 7,875,390 | $37M | hist |
| Marshall Wace - Marshall Wace, LLP 2026 Q1 | 0.0% | Add +0.01 pp | 4,138,176 | $19M | hist |
| Israel Englander - Millennium Management LLC 2026 Q1 | 0.0% | Add +0.01 pp | 3,660,190 | $17M | hist |
| Two Sigma Investments, LP 2025 Q4 stale | 0.0% | Exit -0.01 pp | 1,560,755 | $7M | hist |
| Vanguard Group Inc. 2025 Q4 stale | 0.0% | Reduce 0.00 pp | 8,475,584 | $36M | hist |
| Ken Griffin - Citadel Advisors LLC 2026 Q1 | 0.0% | Add 0.00 pp | 5,406,193 | $25M | hist |
| Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 | 0.0% | Reduce -0.02 pp | 730,844 | $3M | hist |
No managers match this filter.
financials
US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $182.94M | $107.3M | $143.92M |
| Total non-current assets * | $18.86M | $13.23M | $7.64M |
| Total assets | $201.79M | $120.53M | $151.57M |
| Total current liabilities | $155.91M | $85.77M | $46.62M |
| Total non-current liabilities * | $93.33M | $35.22M | $5.94M |
| Total equity | -$47.45M | -$456,000 | $99.01M |
ownership over time
filing count by report period · click a bar for that quarter’s holders